Angus M. Sinclair

3.9k total citations
60 papers, 2.9k citations indexed

About

Angus M. Sinclair is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Angus M. Sinclair has authored 60 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 25 papers in Molecular Biology and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Angus M. Sinclair's work include Monoclonal and Polyclonal Antibodies Research (25 papers), CAR-T cell therapy research (16 papers) and Erythropoietin and Anemia Treatment (13 papers). Angus M. Sinclair is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (25 papers), CAR-T cell therapy research (16 papers) and Erythropoietin and Anemia Treatment (13 papers). Angus M. Sinclair collaborates with scholars based in United States, Germany and United Kingdom. Angus M. Sinclair's co-authors include Steve Elliott, Thomas Hiesberger, Peter Igarashi, Stefan Somlo, C. Glenn Begley, Kimberly R. Cordes, Fangming Lin, Lawrence S.B. Goldstein, Leigh Busse and Yun Bai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Angus M. Sinclair

57 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angus M. Sinclair United States	25	1.6k	917	733	577	419	60	2.9k
Gerwin Huls Netherlands	30	1.9k 1.1×	1.3k 1.4×	378 0.5×	1.1k 1.9×	749 1.8×	115	3.9k
Seth J. Corey United States	35	1.4k 0.9×	996 1.1×	465 0.6×	850 1.5×	1.1k 2.5×	114	3.5k
Hiroshi Handa Japan	28	1.5k 0.9×	1.2k 1.3×	423 0.6×	512 0.9×	666 1.6×	222	3.5k
Edward F. Fritsch United States	18	2.1k 1.2×	985 1.1×	532 0.7×	948 1.6×	1.1k 2.5×	25	4.1k
Stephen C.-T. Lam United States	29	2.3k 1.4×	631 0.7×	316 0.4×	193 0.3×	575 1.4×	37	4.1k
Roman Szabo United States	32	1.6k 1.0×	706 0.8×	303 0.4×	453 0.8×	410 1.0×	55	3.5k
Cheryl D. Helgason Canada	38	3.1k 1.9×	836 0.9×	297 0.4×	882 1.5×	1.8k 4.2×	71	5.2k
Andréas Tsapis France	29	885 0.5×	460 0.5×	257 0.4×	607 1.1×	1.3k 3.1×	71	2.8k
Karin List United States	31	1.2k 0.7×	589 0.6×	206 0.3×	512 0.9×	362 0.9×	42	2.9k
Anne Dubart‐Kupperschmitt France	35	2.2k 1.4×	668 0.7×	708 1.0×	400 0.7×	573 1.4×	109	3.8k

Countries citing papers authored by Angus M. Sinclair

Since Specialization

Citations

This map shows the geographic impact of Angus M. Sinclair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angus M. Sinclair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angus M. Sinclair more than expected).

Fields of papers citing papers by Angus M. Sinclair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angus M. Sinclair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angus M. Sinclair. The network helps show where Angus M. Sinclair may publish in the future.

Co-authorship network of co-authors of Angus M. Sinclair

This figure shows the co-authorship network connecting the top 25 collaborators of Angus M. Sinclair. A scholar is included among the top collaborators of Angus M. Sinclair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angus M. Sinclair. Angus M. Sinclair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Desbois, Mélanie, Thierry Giffon, Kevin C. Hart, et al.. (2025). IGM-7354, an Immunocytokine with IL15 Fused to an Anti–PD-L1 IgM, Induces NK and CD8+ T cell–Mediated Cytotoxicity of PD-L1–Positive Tumor Cells. Cancer Immunology Research. 13(8). 1172–1189. 1 indexed citations

2.

Desbois, Mélanie, Kevin C. Hart, Thomas J. Matthew, et al.. (2024). Abstract 1899: Novel combinations of aplitabart, a DR5 agonist IgM antibody, with ADCs or chemotherapeutic agents lead to robust anti-tumor responses in solid tumor models. Cancer Research. 84(6_Supplement). 1899–1899. 1 indexed citations

3.

Wang, Ling, Thomas J. Matthew, Avneesh K. Saini, et al.. (2021). Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199. Molecular Cancer Therapeutics. 20(12). 2483–2494. 30 indexed citations

4.

Wang, Béatrice, Ling Wang, Avneesh K. Saini, et al.. (2019). Abstract 3050: Multimeric IgM antibodies targeting DR5 are potent and rapid inducers of tumor cell apoptosis and cell death in vitro and in vivo. Cancer Research. 79(13_Supplement). 3050–3050. 2 indexed citations

5.

Wang, Béatrice, Ling Wang, Avneesh K. Saini, et al.. (2019). Abstract 3050: Multimeric IgM antibodies targeting DR5 are potent and rapid inducers of tumor cell apoptosis and cell death in vitro and in vivo. 3050–3050. 1 indexed citations

6.

Harrington, Kimberly H., Chelsea J. Gudgeon, George S. Laszlo, et al.. (2015). The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk. PLoS ONE. 10(8). e0135945–e0135945. 49 indexed citations

7.

McElroy, Patricia, Ping Wei, Angus M. Sinclair, et al.. (2015). Romiplostim promotes platelet recovery in a mouse model of multicycle chemotherapy-induced thrombocytopenia. Experimental Hematology. 43(6). 479–487. 22 indexed citations

8.

Li, Cong, Liqin Liu, Lingming Liang, et al.. (2014). AMG 925 Is a Dual FLT3/CDK4 Inhibitor with the Potential to Overcome FLT3 Inhibitor Resistance in Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 14(2). 375–383. 27 indexed citations

9.

Elliott, Steve, et al.. (2013). Progress in detecting cell-surface protein receptors: the erythropoietin receptor example. Annals of Hematology. 93(2). 181–192. 38 indexed citations

10.

Sinclair, Angus M.. (2013). Erythropoiesis stimulating agents approaches to modulate activity. Biologics. 7. 161–161. 32 indexed citations

11.

Liu, Liqin, Gordon Moody, Jeanne Pistillo, et al.. (2011). Abstract 1975: Discovery of a potent and selective Jak2 inhibitor that suppresses GM-CSF-induced STAT5 phosphorylation and Erythropoietin-induced reticulocytosis in vivo. Cancer Research. 71(8_Supplement). 1975–1975. 1 indexed citations

12.

Liu, Liqin, Jeanne Pistillo, Marc Payton, et al.. (2011). Phosphatidylinsoitol-3 Kinase Delta (PI3Kδ) Inhibitor AMG 319 Combined with Vincristine Enhances G2/M Arrest and Apoptotic Death in Neoplastic B Cells. Blood. 118(21). 4963–4963. 1 indexed citations

13.

Elliott, Steve, Leigh Busse, Ian McCaffery, et al.. (2009). Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells. Journal of Immunological Methods. 352(1-2). 126–139. 56 indexed citations

14.

Binder, Christina, Ivonne Archibeque, Yu Sun, et al.. (2008). Optimization and Utilization of the SureFire Phospho-STAT5 Assay for a Cell-Based Screening Campaign. Assay and Drug Development Technologies. 6(1). 27–37. 17 indexed citations

15.

Sinclair, Angus M., Norma Rogers, Leigh Busse, et al.. (2008). Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells. British Journal of Cancer. 98(6). 1059–1067. 50 indexed citations

16.

Hiesberger, Thomas, Yun Bai, Xinli Shao, et al.. (2004). Mutation of hepatocyte nuclear factor–1β inhibits Pkhd1 gene expression and produces renal cysts in mice. Journal of Clinical Investigation. 113(6). 814–825. 135 indexed citations

17.

Lin, Fangming, Thomas Hiesberger, Kimberly R. Cordes, et al.. (2003). Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proceedings of the National Academy of Sciences. 100(9). 5286–5291. 458 indexed citations

18.

Boudreau, François, Edmond H.H.M. Rings, Gary P. Swain, et al.. (2002). A Novel Colonic Repressor Element Regulates Intestinal Gene Expression by Interacting with Cux/CDP. Molecular and Cellular Biology. 22(15). 5467–5478. 25 indexed citations

19.

Manabe, Noriyo, Hiroshi Kawaguchi, Hirotaka Chikuda, et al.. (2001). Connection Between B Lymphocyte and Osteoclast Differentiation Pathways. The Journal of Immunology. 167(5). 2625–2631. 194 indexed citations

20.

Sinclair, Angus M., Berthold Göttgens, Linda Barton, et al.. (1999). Distinct 5′ SCL Enhancers Direct Transcription to Developing Brain, Spinal Cord, and Endothelium: Neural Expression Is Mediated by GATA Factor Binding Sites. Developmental Biology. 209(1). 128–142. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact